Marimed (MRMD) Total Liabilities (2011 - 2026)

Marimed (MRMD) has reported Total Liabilities for 16 consecutive years, with $147.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities rose 12.09% year-over-year to $147.1 million in Q2 2026; TTM through Jun 2026 was $147.1 million, a 12.09% increase from a year earlier, with the FY2025 full-year figure at $137.8 million, up 6.48% from the prior year.
• Total Liabilities was $147.1 million for Q2 2026 at Marimed, roughly flat from $147.7 million in the prior quarter.
• Over five years, Total Liabilities peaked at $147.7 million in Q1 2026 and troughed at $50.7 million in Q2 2022.
• A 5-year average of $106.1 million and a median of $117.2 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 87.54% in 2023 and gained 6.48% in 2025, its largest moves.
• Over 5 years, Total Liabilities stood at $57.2 million in 2022, then soared by 87.54% to $107.2 million in 2023, then rose by 20.74% to $129.4 million in 2024, then advanced by 6.48% to $137.8 million in 2025, then climbed by 6.69% to $147.1 million in 2026.
• The last three Total Liabilities figures came in at $147.1 million (Q2 2026), $147.7 million (Q1 2026), and $137.8 million (Q4 2025), per Business Quant data.